InChI=1S/C21H36O5.C4H11NO3/c1-3-4-9-13-21(2,26)14-12-17-16(18(22)15-19(17)23)10-7-5-6-8-11-20(24)25;5-4(1-6,2-7)3-8/h5,7,12,14,16-19,22-23,26H,3-4,6,8-11,13,15H2,1-2H3,(H,24,25);6-8H,1-3,5H2/b7-5-,14-12+;/t16-,17-,18+,19+,21+;/m1./s1 |
UMMADZJLZAPZAW-OVXHCKHTSA-N |
[NH3+]C(CO)(CO)CO.CCCCC[C@](C)(O)\C=C\[C@H]1[C@@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC([O-])=O |
|
oxytocic
A drug that stimulates contraction of the myometrium. Oxytocics are used to induce labour, obstetric at term, to prevent or control postpartum or postabortion haemorrhage, and to assess foetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (abortifacients).
abortifacient
A chemical substance that interrupts pregnancy after implantation.
|
|
View more via ChEBI Ontology
(5Z,9α,11β,13E,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oic acid - 2-amino-2-(hydroxymethyl)propane-1,3-diol (1:1)
|
(15S)-15-methyl-PGF2α tromethamine salt
|
ChemIDplus
|
(15S)-15-methylprostaglandin F2α tromethamine
|
ChemIDplus
|
1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9α,11β,13E,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate
|
IUPAC
|
15(S)-15-methyl-PGF2α tromethamine salt
|
ChemIDplus
|
15(S)-15-methylprostaglandin F2α tromethamine
|
ChemIDplus
|
carboprost trometamol
|
ChEBI
|
58551-69-2
|
CAS Registry Number
|
ChemIDplus
|
|